You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國再生醫學(08158.HK)3,500萬售旗下部份銷售業務
阿思達克 08-12 09:53
中國再生醫學(08158.HK)公布,直接全資附屬中國生物醫學再生科技,以3,500萬元出售中國再生醫學組織工程和中國再生醫院投資管理股份,兩間出售公司均處於虧損狀態,估計出售事項收益約460萬元。

股份包括兩集團,其中中國再生醫學組織工程主要從事生產及銷售皮膚科產品及服務、買賣醫療設備、生產及銷售口腔科產品及其他;中國再生醫院投資管理主要從事生產及銷售眼科產品。

公司預期所得款項淨額為3,400萬元,其中600萬會用於員工成本;1,500萬用於研發;1,300萬用於廣告、營銷及推廣開支。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account